MS-20 on Gut Microbiota and Risk/Severity of Cachexia in Pancreatic Cancer Patients
Condition(s):Pancreatic Cancer; Cachexia; Chemotherapy EffectLast Updated:January 19, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Pancreatic Cancer; Cachexia; Chemotherapy EffectLast Updated:January 19, 2023Recruiting
Condition(s):Obesity, Abdominal; Glycation End Products, Advanced; Inflammation; Gut MicrobiotaLast Updated:March 22, 2022Unknown status
Condition(s):Esophagitis; ColitisLast Updated:October 11, 2023Completed
Condition(s):Infant Formula; Estrogen ActivityLast Updated:November 21, 2019Completed
Condition(s):Cystic FibrosisLast Updated:April 25, 2023Completed
Condition(s):Chronic Kidney Disease Stage 5Last Updated:November 1, 2023Active, not recruiting
Condition(s):ObesityLast Updated:May 11, 2018Completed
Condition(s):Healthy ChildrenLast Updated:March 8, 2024Recruiting
Condition(s):Protein-Energy MalnutritionLast Updated:August 23, 2022Not yet recruiting
Condition(s):Diabetes Mellitus, Type 2Last Updated:October 3, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.